Back

Hyperkalaemia in patients with heart failure in German general practices: prevalence, diagnosis and treatment: The WATCH-K study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Optimising care of comorbidities in heart failure Comorbidities ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Ingo Eitel

University Heart Center, Luebeck (Germany)

6 More presentations in this session

Presentation thumbnail
Associations between rapid renal function decline and prior cardiovascular events in patients with heart failure and preserved ejection fraction: insights from the PURSUIT-HFpEF registry
Doctor M. Okada (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Predictors and prognostic impact of chronic kidney disease in hospitalized patients with heart failure - insights from the cardiomining study
Doctor K. Barmpagiannos (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
The impact of GLP-1 receptor agonists on cognitive decline in heart failure patients: a retrospective cohort study using real world data
Associate Professor A. Kalogeropoulos (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics, prescribing patterns and outcomes in individuals with heart failure and type 1 diabetes versus type 2 diabetes
Doctor Y. Liew (Dundee, GB)
Abstract Slides Video
Presentation thumbnail
Low serum iron and transferrin saturation are associated with new-onset heart failure
Doctor C. Cabrera (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising care of comorbidities in heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Hyperkalemia events in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan or sodium-glucose transport protein 2 inhibitors: a single-center experience
thumbnail
Congress Presentation
Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalaemia: insights from the CARE-HK in HF registry
thumbnail
Congress Presentation
Hyperkalemia prevalence in ambulatory patients with chronic heart failure and reduced ejection fraction in a third level center

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources